CALQUENCE vs RAPAMUNE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. CALQUENCE and RAPAMUNE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CALQUENCE	RAPAMUNE
Rating	70/100	New
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	ACALABRUTINIB	SIROLIMUS
Manufacturer	Astrazeneca	Pf Prism Cv
Dosage forms	Capsule, Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Mantle-Cell Lymphoma	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

calquence rapamune

Rating

70/100

New

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

ACALABRUTINIB

SIROLIMUS

Manufacturer

Astrazeneca

Pf Prism Cv

Dosage forms

Capsule, Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Mantle-Cell Lymphoma

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Calquence and Rapamune?

Calquence contains Acalabrutinib, while Rapamune contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.